BROOKFIELD, Wis., Nov. 02, 2017 -- Connecture, Inc. (OTCQX: CNXR), a provider of web-based information systems used to create health insurance marketplaces, will release its 2017 third quarter financial results on Thursday, November 9, after market close and will host a conference call to follow at 5:00 p.m. Eastern Time.
Shareholders and interested participants who would like to listen to a live broadcast of the conference call may dial (877) 930-8068 (domestic) or (253) 336-8043 (international) and reference participant code 9189465 approximately 15 minutes prior to the call.
A live webcast of the conference call will be available on the investor relations section of the company’s website, and an audio file of the call will be archived for 30 days. After the conference call, a replay will be available until November 16, 2017, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, and referencing participant code 9189465.
About Connecture
Connecture (OTCQX: CNXR) is a leading web-based consumer shopping, enrollment and retention platform for health insurance distribution. Connecture offers a personalized health insurance shopping experience that recommends the best fit insurance plan based on an individual’s preferences, health status, preferred providers, medications and expected out-of-pocket costs. Connecture’s customers are health insurance marketplace operators, such as health plans, brokers and exchange operators, who must distribute health insurance in a cost-effective manner to a growing number of insured consumers. Connecture’s solutions automate key functions in the health insurance distribution process, allowing its customers to price and present plan options accurately to consumers and efficiently enroll, renew and manage plan members.
Investor Relations Contact:
Vincent Estrada
Chief Financial Officer
Connecture, Inc.
(262) 432-8282
[email protected]
Media Contact:
Jeff Hyman
Channel Marketing Director
Connecture, Inc.
(818) 415-2569
[email protected]


Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



